








 |
CGMH
Administration
Center |
No.199, Tunghwa Rd.,
Taipei, Taiwan, R.O.C |

886-2-27135211 |
|
|
|
Supernumerary Chromosome Marker Der(22)t(11;22)
Resulting from a Maternal Balanced Translocation |
 |
 |
 |
| Derivative 22 [der(22)] syndrome is a rare disorder associated
with multiple congenital anomalies including pre-auricular
skin tags or pits, conotruncal heart defects, and profound
mental retardation. Der(22)t(11;22) is one of the causes of
supernumerary chromosome markers (mar) in humans. We present
a boy with developmental delay and multiple anomalies consistent
with the supernumerary der(22) syndrome. Cytogenetic analysis
showed an abnormal chromosome complement of 47, XY, +mar in
all 50 cells analyzed. The karyotype of his mother showed
a reciprocal translocation over the distal bands 11q23 and
22q11, respectively, i.e., 46,XX,t(11;22)(q23.3;q11.2), and
that of his father was 46,XY. Thus, the nature of the supernumerary
chromosome markers was of der(22)t(11;22)(q23.3;q11.2). The
clinical features, including craniofacial dysmorphism, hypotonia,
psychomotor retardation, heart defects, and urogenital anomalies,
were the combined effects of partial trisomies for both distal
11q and pericentromeric 22q. (Chang Gung Med J 2003;26:48-52)
KeywordsĦG
der(22), t(11;22), supernumerary marker, partial trisomy 11,
partial trisomy 22. |
| |
 |
| A reciprocal translocation between chromosomes 11 and 22
is a site-specific translocation that has been seen in many
family members with no common ancestry.(1) This translocation
is of particular interest because male and female balanced carriers
have a 0.7 % and 3.7% risk of having children with the supernumerary
der (22), respectively.(2) The t(11;22)(q23;q11) translocation
is also the most frequently identified familial reciprocal translocation
in humans.(1,3) The unbalanced offspring of such translocation
carriers usually present with supernumerary derivatives of chromosome
22, i.e., der(22)t(11;22). The supernumerary der(22)t(11;22)
syndrome is characterized by mental deficiency, malformed ears
with pre-auricular pits or tags, high-arched or cleft palates,
micrognathia, and congenital heart defects.(3) The reported
neurological abnormalities have also included microcephaly,
delayed psychomotor development, and dilated ventricles of brain.(1-5)
In the translocation carrier, 3:1 meiotic segregation with tertiary
trisomy can occur, resulting in abnormal progeny with the der(22)
as the supernumerary chromosome markers.(3-5) However, this
supernumerary marker, especially the de novo form, is often
misdiagnosed as chromosome 22 or others.(5,6) I present a boy
with non-mosaic supernumerary der(22)t(11;22) syndrome resulting
from a maternal balanced reciprocal translocation.
CASE REPORT
My boy patient was the first child of healthy, young parents
born at the gestational age of 39 weeks via Cesarean section
due to breech presentation and fetal distress. His prenatal
life was complicated with oligohydramnios and small kidneys,
which were detected on sonography. He was small for his age
with head circumference (HC) of 31 cm, body weight (BW) of
2578 g and body height (BH) of 47 cm. Dyspnea, poor feeding,
oliguria and cyanosis developed at birth. He was hospitalized
due to severe dehydration with acute renal failure at 1 month
of age, when postnatal growth retardation was apparent (HC,
32.0 cm; BW, 3200 g; and BH, 49 cm, all below the 3rd percentile).
On physical examination, he has microcephaly with frontal
bossing, wrinkled forehead, hypopigmented hair and skin, scanty
eyebrows and hair, ptosis of the left eye, epicanthal folds,
downward slanting palpebral fissures, flat tip to the nose
due to a short septum, increased naso-labial distance with
a well-formed and prominent philtrum, thick lips, high-arched
palate, micrognathia, underdeveloped ears, bilateral preauricular
pits (Fig. 1), and bilateral inverted nipples. A grade II/VI
systolic murmur over the precordial area was detected. Both
little fingers had four phalanges. Cubitus valgus and flexion
contraction over the left elbow was noted. In addition to
right cryptorchism, bilateral hydrocele and micropenis were
found. Thyroid function and electrolytes (calcium, phosphate,
sodium and potassium) were normal. The initial renal function
was impaired with elevated levels of blood urea nitrogen (from
80 to 58 mg/dL) and creatinine (from 2.4 to 1.4 mg/dL). Ophthalmologic
examination revealed hypopigmented fundus, but no coloboma.
Echocardiogram showed a patent ductus arteriosus (PDA), a
type II atrial septal defect (ASD II), pulmonary valve stenosis
with hypoplastic annulus, and an aberrant right subclavian
artery. Brain echography showed moderate dilatation of lateral
ventricles and hypoplastic corpus callosum. Renal echography
showed hypoplastic kidneys with increased echogenecity. Auditory
brain stem evoked potential study showed peripheral sensorineural
hearing impairment over the left side. A tentative diagnosis
of branchio-oto-renal (BOR) syndrome was made. Chromosome
study of the patient showed an abnormal karyotype: 47,XY,
+mar (Fig. 2A) in all 50 cells analyzed. Further study of
his mother showed 46,XX,t(11;22)(q23.3;q11.2)] (Fig. 2B) and
father 46,XY. The chromosomal complement of the proband was
thus 47, XY, +der (22) t(11;22)(q23.3; q11.2) mat. Ligations
of the PDA and pulmonary valvulotomy with patch closure of
ASD II were performed at the ages of 3 months and 14 months,
respectively.
During the following 3 years of follow-up, microcephaly, failure
to thrive, short stature, and motor delay persisted despite
participation in a rehabilitation program. At 3 years of age,
he could not stand, with HC of 45.3 cm (<3rd percentile).
At 4 years of age, he had ataxic gait and could only speak
simple words. His HC was 46.5 cm (<3rd percentile), weight
was 11 kg (<3rd percentile), and height was 92.5 cm (3~10th
percentile). Magnetic resonance images of his brain showed
plagiocephaly without other structural anomalies. Results
of the renal function test and urinalysis were normal.
DISCUSSION
This patient was noted to have multiple congenital anomalies
and developmental delays after birth. Chromosomal study showed
an extra chromosome marker of the G-group size. Small supernumerary
marker chromosomes have rarely been seen in routine cytogenetic
analysis. The patient did not have the phenotype of Down syndrome
(trisomy 21). True complete trisomy 22 was not considered
because it is not compatible with life. From the karyotypes
of the parents, the nature of the supernumerary marker was
delineated as the composition: 22pter-22q11.2:11q23.3-11qter.
Identification of the marker chromosomes delineated the clinical
effects of specific extra genetic materials on the proband,
and helped us to understand how markers form and to perform
genetic counseling.(6) Reciprocal translocation t(11;22)(q23;q11)
is of particular interest because the unbalanced offspring
of the translocation carriers usually present with a supernumerary
derivative of chromosome 22.
The constitutional t(11;22) translocation is the only known
recurrent non-Robertsonian translocation in humans.(1,3) Carriers
are phenotypically normal and often remain undetected until
diagnosis due to infertility or the birth of chromosomally
unbalanced offspring. Supernumerary der(22)t(11;22) syndrome
can occur in the progeny of balanced t(11;22) carriers, because
of malsegregation of the der(22).(3-5) Der(22) syndrome patients
carry a der(22)t(11;22) (q23;q11) chromosome and are therefore
trisomic for 11q23-qter and 22pter-q11. The main features
are moderate mental retardation, mild craniofacial anomalies,
genital abnormalities, and congenital heart defects.(1-5)
BOR syndrome should be considered as a differential diagnosis
in this patient. BOR syndrome is defined by the presence of
at least three of the four following major features: hearing
loss, branchial clefts, ear pits, and renal abnormalities.(7)
It is an autosomal dominant disorder with considerable variability
of phenotype within families. Mutations in the EYA1 gene (localized
to 8q13.3) have been identified in nearly 70% of BOR syndrome
cases.(7) Der(22) syndrome may account for some cases with
BOR phenotype when mutations undetected.
Maternal transmission of this unbalanced translocation was
concluded,(2,5) but the underlying mechanisms are not clear.
Furthermore, the chromosome 22q11 region was susceptible to
rearrangements because this area contains low copy repeats
(LCR) sequence block (i.e., the break-prone region 22q11.2).
The existence of LCR22S may mediate a number of distinct rearrangements
on 22q11 by homologous recombination mechanisms leading to
several congenital anomaly disorders.(1) They include deletion
diseases such as velo-cardio-facial syndrome/DiGeorge anomaly,
duplications in cat-eye syndrome and der(22) syndrome, or
genetic disorders such as chronic myelogenous leukemia caused
by t(9;22). Most cases occur sporadically in the population,
suggesting that this region is prone to chromosome rearrangements.(1,4,8)
In addition, the formation of a hairpin in palindromic AT-rich
sequences flanking both the chromosome 11 and the chromosome
22 breakpoints may generate the t(11;22) translocation.(8,9)
The chromosomal region 11q23 may involve CDREL 1 and MLL genes.
Balanced carriers may be at increased risk for neoplasia due
to the involvement of the genes in tumorigenesis on 11q23.
The finding of a significant association between breast cancer
and the constitutional translocation t(11;22)(q23;q11) suggests
involvement of additional breast cancer gene(s) on 11q23,
22q11, or both. The patients with t(11;22) may be prone to
the development of breast cancer.(10) However, this translocation
does not seem to directly disrupt any active gene or generation
of an aberrant fusion gene. A comprehensive array-based analysis
of genes located near both translocation breakpoints is a
possible way to solve this question. |
 |
 |
| REFERENCES
1. Iselius L, Lindsten J, Aurias A, Fraccaro M, Bastard
C, Bottelli AM, Bui TH, Caufin D, Dalpra L, Delendi N. The
11q;22q translocation: a collaborative study of 20 new cases
and analysis of 110 families. Hum Genet 1983;64: 343-55.
2. Gardner RJH, Sutherland GR. Chromosome
Abnormali-ties and Genetic Counseling. Oxford: Oxford University
Press, 1996:29-46.
3. Donnenfeld AE, Zackai EH, Emanuel BS.
Chromosome 22, supernumerary der 22, t(11;22). In: Buyse ML
(Ed.). Birth Defects Encyclopedia. Cambridge: Blackwell 1990:394-5.
4. Simi P, Ceccarelli M, Baracchini A, Floriani
G, Zuffardi O. The unbalanced offspring of the male carriers
of the 11q;22q translocation: non-disjunction at meiosis II
in a balanced spermatocyte. Hum Genet 1996;88:482-3.
5. Fraccaro M, Lindsten J, Ford CE, Iselius
L. The 11q;22q translocation: a European collaborative analysis
of 43 cases. Hum Genet 1980;56:21-51.
6. Hou JW, Liu CH, Wang TR. Molecular cytogenetic
studies of children with marker chromosomes. J Formos Med
Assoc 1994;93:205-9.
7. Rickard S, Boxer M, Trompeter R, Bitner-Glindzicz
M. Importance of clinical evaluation and molecular testing
in branchio-oto-renal (BOR) syndrome and overlapping phenotypes.
J Mol Genet 2000;37:623-7.
8. Tapia-Paez I, Kost-Alimova M, Hu P, BoeBA,
Blennow E, Fedorova L, Imreh S, Dumanski JP. The position
of t(11;22)(q23;q11) constitutional translocation breakpoint
is conserved among its carriers. Hum Genet 2001;109: 167-77.
9. Kurahashi H, Shaikh TH, Zackai EH, Celle
L, Discoll DA, Budarf ML, Emanuel BS. Tightly clustered 11q23
and 22q11 breakpoint permit PCR-based detection of the recurrence
constitutional t(11;22). Am J Hum Genet 2000; 67:763-8.
10. Lindblom A, Sandelin K, Iselius L, Dumanski
J, White I, Nordenskjold M, Larsson C. Predisposition for
breast cancer in carriers of constitutional translocation
11q;22q. Am J Hum Genet 1994;54:871-6. |
 |
 |
| From the Division of Medical Genetics, Department of
Pediatrics, Chang Gung Children's Hospital, Taoyuan.
Received: Apr. 12, 2002; Accepted: May 31, 2002
Address for reprints: Dr. Jia-Woei Hou, Division of Medical
Genetics, Department of Pediatrics, Chang Gung Children's
Hospital. 5-7, Fu-Shin St. Kweishan, Taoyuan 333, Taiwan,
R.O.C. Tel.: 886-3-3281200 ext. 8203; Fax: 886-3-3278283;
E-mail: houjw741@cgmh.org.tw |
|